Vuong Do, PhD, received his doctorate in Public Health (Epidemiology) from the School of Public Health, Georgia State University. During his four years at Georgia State, he received the Second Century Initiative fellowship and worked as a graduate research assistant for faculty members of the tobacco control group.
Arthur (Arturo) Durazo is a health psychologist with an emphasis on behavioral medicine, eHealth/mHealth interventions, and health equity. His research focuses on psychosocial factors that promote protective behaviors among those with disproportionate burdens of illness associated with membership in low socioeconomic and ethnic minority groups.
Samantha Filby, is an Economics PhD candidate at University of Cape Town (South Africa) and is sponsored by a Fulbright Scholarship to visit the Center for Tobacco Control Research and Education. She serves as a member of the research team at the Research Unit on the Economics of Excisable Products, based at her home university.
Nadia Gaber, PhD received her PhD from the joint program in medical anthropology from UCSF and UC Berkeley, and is obtaining her MD at UCSF with support from the National Institutes of Health and Medical Scientist Training Program. Her research on the politics of urban health and safety in the U.S.
Sheiphali Gandhi, MD, is a pulmonologist specializing in occupational and environmental respiratory disease. She graduated from Indiana University School of Medicine in 2012. She went to the University of Minnesota for her internal medicine residency and global health chief residency during which she received her Certificate in Tropical Medicine through the Center of Disease Control and American Society of Tropical Medicine and Hygiene.
My research concentrates on oral health research, health disparities research, applied statistical analyses and related methodological issues. Balancing these components is essential to successful and practical oral epidemiology research. Methodological examination helps ground health research and build convincing arguments, while collaborative health research generates opportunities for innovative statistical practice and provides challenges for developing ways to solve real world problems
Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.
Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.
Scarlett Lin Gomez, M.P.H. and Ph.D. in Epidemiology, is Professor in the Department of Epidemiology and Biostatistics and a member of the Helen Diller Family Comprehensive Cancer Center, where she is Co-Leader of the Cancer Control Program and a member of the Prostate Cancer Program Leadership Committee. She is Director of the Greater Bay Area Cancer Registry, a participant in the NCI SEER (Surveillance, Epidemiology, End Results) program and the California Cancer Registry.
Research focuses on the effects of cigarette smoke and e-cigarette aerosols on susceptibility to acute respiratory distress syndrome (ARDS), a major cause of respiratory failure in critically ill patients.
Associate Vice Chancellor, Clinical and Translational Science Institute
Otolaryngology
Dr. Jennifer R. Grandis received her medical degree from the University of Pittsburgh School of Medicine, Pennsylvania, and completed her internship from the same institution. Dr. Grandis completed both a residency and an Infectious Disease fellowship from the University of Pittsburgh School of Medicine, Pennsylvania. Prior to joining UCSF, Dr. Grandis was the UPMC Endowed Chair in Head and Neck Cancer Surgical Research and Distinguished Professor of Otolaryngology and Pharmacology and Chemical Biology at the University of Pittsburgh.
